These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32703387)

  • 41. Delayed lymph node metastasis of excised caruncular sebaceous carcinoma in an atypical demographic.
    Eneh A; Farmer J; Kratky V
    Can J Ophthalmol; 2014 Oct; 49(5):e118-9. PubMed ID: 25284114
    [No Abstract]   [Full Text] [Related]  

  • 42. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
    Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
    Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
    Chao AN; Shields CL; Krema H; Shields JA
    Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sebaceous Carcinoma of the Ocular Region: The 2014 Professor Winifred Mao Lecture.
    Shields JA; Saktanasate J; Lally SE; Carrasco JR; Shields CL
    Asia Pac J Ophthalmol (Phila); 2015; 4(4):221-7. PubMed ID: 26147013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sebaceous carcinoma of the eyelid: a clinicopathological study.
    Zürcher M; Hintschich CR; Garner A; Bunce C; Collin JR
    Br J Ophthalmol; 1998 Sep; 82(9):1049-55. PubMed ID: 9893597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
    Jakobiec FA; Mendoza PR
    Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
    Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
    Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
    Kan LW; Leu YS; Tzen CY; Wu CH
    Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytologic features of metastatic sebaceous carcinoma: report of two cases with comparison to three cases of basal cell carcinoma.
    Sadeghi S; Pitman MB; Weir MM
    Diagn Cytopathol; 1999 Nov; 21(5):340-5. PubMed ID: 10527482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
    Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
    Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma.
    Muqit MM; Foot B; Walters SJ; Mudhar HS; Roberts F; Rennie IG
    Br J Ophthalmol; 2013 Jan; 97(1):47-51. PubMed ID: 23117971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrasound biomicroscopic appearances of eyelid lesions at 50 MHz.
    Bajaj MS; Aalok L; Gupta V; Sen S; Pushker N; Chandra M
    J Clin Ultrasound; 2007 Oct; 35(8):424-9. PubMed ID: 17551943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus.
    Yen MT; Tse DT
    Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):206-10. PubMed ID: 10826761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
    Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
    Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
    Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sebaceous carcinoma of meibomian gland origin. The diagnostic importance of pagetoid spread of neoplastic cells.
    Russell WG; Page DL; Hough AJ; Rogers LW
    Am J Clin Pathol; 1980 Apr; 73(4):504-11. PubMed ID: 7369174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
    Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K; Font RL
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sebaceous carcinoma. Study of two cases].
    Iglesias I; Troyano J; Díaz-Valle D; Genol I
    Arch Soc Esp Oftalmol; 2008 Jul; 83(7):445-8. PubMed ID: 18592447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.